As the survival of patients with cystic fibrosis (CF) improves, it becomes increasingly
important to address such issues as employment, reproduction, and quality of life in …

Purpose People living with cystic fibrosis (CF) experience impaired quality of life, but the
extent to which pulmonary function is associated with quality of life in CF remains unclear …

Since the first published report of mortality in cystic fibrosis in 1969, the median survival
among cystic fibrosis patients has risen from 14 to 31 years. The reasons for this improved …

Rationale: Patients of Hispanic origin with cystic fibrosis (CF) are the largest growing
minority, representing 8.5% of patients with CF in the United States. No national survival …

Cystic fibrosis (CF) is a life-shortening disease with significant morbidity. Despite overall
improvements in survival, patients with CF experience frequent pulmonary exacerbations …

Background: Cystic fibrosis (CF) affects more than 80,000 people worldwide, having a
considerable impact on the quality of life of patients and their caregivers, who assist patients …

The natural history of cystic fibrosis (CF) is an evolving phenomenon. As such, it is
continually being redefined as epidemiologic data is collected and processed and as …

Objectives Cystic fibrosis (CF) is an inherited disease that requires more intensive
treatments as the disease progresses. Recent medical advancements have improved …

Background Health-related quality-of-life (HRQOL) measures have been used as patient-
reported outcomes in clinical trials in cystic fibrosis (CF), but there are limited data on …

Background Median survival age in cystic fibrosis (CF) has increased in developed
countries. Scarce literature exists about survival in Latin America, especially in Mexico. The …